In 2003, Abbott raised the price of a Norvir course from $1.71 per day to $8.57 per day, leading to claims of price gouging by patients' groups and some members of Congress. Consumer group Essential Inventions petitioned the NIH to override the Norvir patent, but the NIH announced on August 4, 2004 that it will not invoke its legal right to allow generic production of Norvir, citing potential adverse effects on the pharmaceutical market.
NIH Won't Intervene in AIDS Drug Pricing Issue (http://www.washingtonpost.com/wp-dyn/articles/A40430-2004Aug4.html)
Share your thoughts, questions and commentary here
Want to know more? Search encyclopedia, statistics and forums:
Press Releases |
The Wikipedia article included on this page is licensed under the
Images may be subject to relevant owners' copyright.
All other elements are (c) copyright NationMaster.com 2003-5. All Rights Reserved.
Usage implies agreement with terms, 1022, m